Serina Therapeutics, Inc. (SER) Operating margin 2017–2025
Serina Therapeutics, Inc. (SER) operating margin by fiscal year — reported operating income divided by reported revenue.
-18478.5%FY2025 · since FY2017: -474.6% → -18478.5%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -18478.5% | +11964.4 pp |
| FY2024 | -30442.9% | -30343.6 pp |
| FY2023 | -99.2% | +20415.5 pp |
| FY2022 | -20514.7% | -15005.7 pp |
| FY2021 | -5509.0% | -2711.2 pp |
| FY2020 | -2797.8% | -2071.0 pp |
| FY2019 | -726.8% | +78.7 pp |
| FY2018 | -805.5% | -330.9 pp |
| FY2017 | -474.6% | — |
Operating margin = reported operating income ÷ reported revenue for the same fiscal year. Operating-loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice